| | POLISH FINANCIAL SUPERVISION AUTHORITY | | | | | | | UNI - EN REPORT No | 44 | / | 2016 | | | | | | Date of issue: | 2016-05-11 | | | | | | | | | | | Short name of the issuer | | | | | | | | | | SOPHARMA AD | | | | Subject | | | | | | | | | | | | | Notification | | | | Official market - legal basis | | | | | | | | | Inne uregulowania | | | | Unofficial market - legal basis | | | | | | | | Contents of the report: | | | | | | | | | | | The Board of Directors of SOPHARMA AD _the “Company"_ hereby informs that for April 2016 Sopharma AD realized a decrease of sales revenues of 19% compared to the same month of last year, including retention of the level of domestic sales and 29% decrease of export sales.
For the first four months of 2016 sales revenues decreased by 4% compared to the same period of 2015, including a 6% increase of domestic sales and a 10% decrease of export sales. In the past two months there has been a sharp decline in the purchasing power of the population in Russia and conservative use of resources by households as the indexation of the prices has outpaced the indexation of wages. We expect that this trend will continue in the summer months, which are traditionally weak.
| | | | Annexes | | | | | | | | | | | | | File | Description | | | | | Notification | | |
